| |
| |
|
| Insider
Information: |
Zante Greg |
| Relationship: |
Chief Financial Officer |
| City: |
Richmond |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
175,547 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,715,581 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
175,547 |
|
|
| Total
Value |
$11,715,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 271.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sangamo Biosciences Inc |
SGMO |
VP, Finance & Administ... |
2008-02-14 |
693 |
2004-09-29 |
0 |
Premium* |
|
|
Viking Therapeutics, Inc. |
VKTX |
Chief Financial Officer |
2024-05-03 |
174,854 |
2021-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SGMO |
Sangamo Biosciences Inc |
Sr Dir., Finance & Admin |
• – – |
2004-09-29 |
4 |
OE |
$3.00 |
$16,248 |
D/D |
5,416 |
5,416 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
Sr Dir., Finance & Admin |
• – – |
2004-09-29 |
4 |
S |
$5.05 |
$27,351 |
D/D |
(5,416) |
0 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
Sr. Director Finance & Admin |
• – – |
2006-06-01 |
4 |
OE |
$3.00 |
$24,000 |
D/D |
8,000 |
8,000 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
Sr. Director Finance & Admin |
• – – |
2006-06-01 |
4 |
S |
$7.90 |
$63,200 |
D/D |
(8,000) |
0 |
|
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Finance & Administration |
• – – |
2006-12-11 |
4 |
S |
$7.04 |
$193,016 |
D/D |
(27,417) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Finance & Administration |
• – – |
2006-12-11 |
4 |
OE |
$3.00 |
$132,038 |
D/D |
27,417 |
9,583 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Finance & Administration |
• – – |
2006-12-11 |
4 |
D |
$7.04 |
$5,822 |
D/D |
(827) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Finance & Administration |
• – – |
2006-12-12 |
4 |
OE |
$4.11 |
$51,375 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Finance & Administration |
• – – |
2006-12-12 |
4 |
S |
$6.98 |
$87,250 |
D/D |
(12,500) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2007-11-08 |
4 |
OE |
$3.00 |
$44,574 |
D/D |
11,858 |
8,108 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2007-11-08 |
4 |
S |
$18.03 |
$225,375 |
D/D |
(12,500) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2007-12-07 |
4 |
AS |
$15.53 |
$78,995 |
D/D |
(5,000) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2007-12-07 |
4 |
OE |
$4.11 |
$21,887 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2008-01-08 |
4 |
OE |
$4.11 |
$23,920 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2008-01-08 |
4 |
AS |
$12.59 |
$64,370 |
D/D |
(5,000) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Finance & Administration |
• – – |
2008-02-14 |
4 |
AS |
$12.00 |
$1,200 |
D/D |
(100) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
VP, Finance & Administration |
• – – |
2008-02-14 |
4 |
OE |
$4.11 |
$411 |
D/D |
100 |
100 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2008-02-14 |
4 |
AS |
$12.00 |
$60,095 |
D/D |
(5,000) |
0 |
0 |
- |
|
| SGMO |
Sangamo Biosciences Inc |
Vice President, Fin. & Admin. |
• – – |
2008-02-14 |
4 |
OE |
$4.11 |
$24,826 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
71,450 |
93,346 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
D |
$5.80 |
$16,165 |
D/D |
(2,787) |
90,559 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-01-19 |
4 |
D |
$6.68 |
$5,397 |
D/D |
(808) |
89,751 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-28 |
4 |
D |
$6.50 |
$14,989 |
D/D |
(2,306) |
94,485 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
6,667 |
96,791 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-03 |
4 |
D |
$4.88 |
$15,113 |
D/D |
(3,097) |
91,806 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
